Pharmaceutical Executive February 28, 2024
Mike Hollan

The device can detect potential warning signs of serious conditions.

Reese Pharmaceutical is launching a new at home colon cancer screening test as part of its diagnostic portfolio. The over-the-counter test is FDA approved and is available now.

According to a press release,1 the test is a fecal immunochemical test and is able to detect blood in the stool, even if it is not visible to the naked eye. This can be used as an early warning sign of colon cancer, along with other conditions like diverticulitis and polyps. The test has a suggested retail price of $19.99.

In a press release, Reese Pharmaceutical’s president Jeffrey Reese said, “90% of colon cancer-related deaths are thought to be preventable if caught...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Home, Medical Devices, Patient / Consumer, Provider
University of Rochester Medical Center plans hospital-at-home program
Hospital-at-Home: Bridging Inpatient and Remote Care
Why Saint Luke's plans to expand hospital at home
Meet the Company Developing an At-Home Test to Replace the Pap Smear
AdventHealth Rolls Out New Hospital-At-Home Program

Share This Article